Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT07268469
Eligibility Criteria:
Inclusion Criteria:
* Provision of informed consent
* Age ≥18 years
* Eligibility for potentially-curative surgery, regardless of previous neoadjuvant/pre-operative systemic treatment
* Completed adequate pre-surgical staging procedures as per standard clinical practice
* Diagnosis of one of the following:
* Clinical Stage II or III breast cancer
* Clinical Stage II or III NSCLC
* HGSOC, either relapsed after primary treatment, confirmed by biopsy, or suspected on the basis of radiological criteria
* Prostate cancer, with at least one of the following: Gleason Score ≥8, radiologically ≥cT2c, or PSA \>10
* Gastric cancer with at least one of the following: Radiological/ecoendoscopic/laparoscopic evidence of node-positive disease, infiltration of the serosa or the surrounding organs, diffuse subtype as histology.
Exclusion Criteria:
* Unable to provide informed consent
* Unable to undergo surgery
* Radiological evidence of metastatic disease
* Unwilling to be subjected to longitudinal plasma samples collection
* Prior diagnosis of a malignant tumor for which the patients underwent any type of anti-neoplastic treatment within 2 years prior to the study screening
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07268469
Study Brief:
Protocol Section:
NCT07268469